This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Neurology Advisor

Eculizumab Safe, Tolerable for Refractory Generalized Myasthenia Gravis
Neurology Advisor
Eculizumab is safe, tolerable, and produces similar effects to placebo on activities of daily living for patients with anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis, according to results from a phase 3, double ...



The Assistance Fund Opens Copay Program for Individuals with ...
Business Wire (press release)
The Assistance Fund is now providing financial support for insurance, deductibles, copays and medical expenses for individuals with myasthenia gravis.

and more »


Familial aggregation of myasthenia gravis in affected families: a population-based study
Dove Medical Press
Introduction: Myasthenia gravis (MG) is clinically heterogeneous and can be life-threatening if bulbar or respiratory muscles are involved. However, relative contributions of genetic, shared, and nonshared environmental factors to MG susceptibility ...



Drug Discovery & Development

FDA Approves Soliris for Generalized Myasthenia Gravis
Drug Discovery & Development
The U.S. Food and Drug Administration (FDA) has approved eculizumab (Soliris) as a treatment for adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody-positive. Approval was granted to Alexion ...



Study Explains Why MuSK MG Patients Relapse After Rituxan Therapy
Myasthenia Gravis News
“Disease relapse following successful rituximab [Rituxan] treatment could be predicted, allowing physicians to tailor therapy on an individual basis,” said Richard Nowak, MD, co-senior author of the study and director of the Yale Myasthenia Gravis Clinic.



Relatives of Myasthenia Gravis Patients More Prone to Developing the Disease, Study Suggests
Myasthenia Gravis News
In this study, authors evaluated the familial aggregation and heritability of myasthenia gravis and the relative risks of other autoimmune diseases in the relatives of patients. They performed a population-based family study using the Taiwan National ...



Myasthenia Gravis News

Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US
Myasthenia Gravis News
The National Organization for Rare Disorders (NORD) says it's “disappointed and dismayed” after the House of Representatives voted 227-205 last week to repeal the Orphan Drug Tax Credit as part of a U.S. tax reform package. A similar package before the ...

and more »


Myasthenia Gravis News

Korean Study Urges Flu Vaccine for MG Patients to Prevent Disease Complications
Myasthenia Gravis News
The risk of aggravating myasthenia gravis (MG) is higher in patients who develop influenza-like illness (ILI) than those who have been vaccinated against influenza vaccination, indicating that people with MG should be immunized, a study finds. The ...

and more »


Medgadget (blog)

Myasthenia Gravis Drugs Market Analysis, Market Size, Regional ...
Medgadget (blog)
This report titled “Global Myasthenia Gravis Drugs Market – Growth, Future Scenarios and Competitive Analysis, 2017 – 2025”. The Global Market study provid.

and more »


Cognitive Behavioral Therapy Could Help MG Patients with Anxiety, Depression or Insomnia
Myasthenia Gravis News
Cognitive Behavioral Therapy (CBT) should be considered as a first-line treatment for myasthenia gravis (MG) patients who also suffer from anxiety, depression, or insomnia disorders, a new study urges. The study, “Cognitive-Behavioral Therapy for ...


Google News